BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31952999)

  • 21. A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.
    Lotan Y; Daneshmand S; Shore N; Black P; Scarpato KR; Patel A; Lough T; Shoskes DA; Raman JD
    J Urol; 2024 Jul; 212(1):41-51. PubMed ID: 38700731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.
    Woldu SL; Ng CK; Loo RK; Slezak JM; Jacobsen SJ; Tan WS; Kelly JD; Lough T; Darling D; van Kessel KEM; de Jong JJ; van Criekinge W; Shariat SF; Hiar A; Brown S; Boorjian SA; Barocas DA; Svatek RS; Lotan Y
    J Urol; 2021 May; 205(5):1387-1393. PubMed ID: 33356483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    Ramirez D; Gupta A; Canter D; Harrow B; Dobbs RW; Kucherov V; Mueller E; Streeper N; Uhlman MA; Svatek RS; Messing EM; Lotan Y
    BJU Int; 2016 May; 117(5):783-6. PubMed ID: 26435378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
    van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
    J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Nomogram Allowing Physicians to Predict Patients at High Risk of Fever Occurring After Prostate Biopsy.
    Xia H; Wang H; Chen L; Meng J; Zhou J; Liang C
    Med Sci Monit; 2020 Mar; 26():e921350. PubMed ID: 32200388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms.
    Wu JM; Williams KS; Hundley AF; Jannelli ML; Visco AG
    Am J Obstet Gynecol; 2006 May; 194(5):1423-6. PubMed ID: 16579943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hematuria in urothelial neoplasia.
    Shenoy UA; Schumann GB; DeBellis CC
    Am J Clin Pathol; 1986 Jan; 85(1):80-2. PubMed ID: 3940425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract.
    Ordell Sundelin M; Jensen JB
    Scand J Urol; 2017 Oct; 51(5):373-375. PubMed ID: 28644736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can reproductive characteristics predict bladder cancer in women with haematuria?
    Yavuzcan A; Caglar M; Kayikci MA; Basaran E; Tekin A; Ozdemir E; Dilbaz S; Ustun Y; Cam HK
    Asian Pac J Cancer Prev; 2013; 14(9):5107-10. PubMed ID: 24175784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A predictive nomogram for mortality of cancer patients with invasive candidiasis: a 10-year study in a cancer center of North China.
    Li D; Li T; Bai C; Zhang Q; Li Z; Li X
    BMC Infect Dis; 2021 Jan; 21(1):76. PubMed ID: 33446133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a predictive model for the diagnosis of bladder tumors using narrow band imaging.
    Liang H; Yang Q; Zhang Y; Sun H; Fu Q; Diao T; Wang J; Huang W; Xu Y; Ge N; Jiang X; Chen S; Li Y; Zhou B; Li P; Zhang X; Zhang N; Shi B; Chen J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15867-15877. PubMed ID: 37672077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
    Rud E; Galtung KF; Lauritzen PM; Baco E; Flatabø T; Sandbæk G
    Eur Radiol; 2020 Mar; 30(3):1664-1670. PubMed ID: 31748856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Microscopic Hematuria Guidelines as Applied in 1018 Patients With Microscopic Hematuria.
    Sancı A; Oktar A; Gokce MI; Süer E; Gülpinar O; Gögüs C; Baltacı S; Turkolmez K
    Urology; 2021 Aug; 154():28-32. PubMed ID: 33971192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of computed tomographic urography for the detection of bladder tumors in patients with microscopic hematuria.
    Aguilar-Davidov B; Ramírez-Muciño A; Culebro-García C; Sotomayor M; Castillejos-Molina R; Feria-Bernal G; Rodríguez-Covarrubias F
    Actas Urol Esp; 2013; 37(7):408-11. PubMed ID: 23398811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis.
    Yao Z; Zheng Z; Ke W; Wang R; Mu X; Sun F; Wang X; Garg S; Shi W; He Y; Liu Z
    J Transl Med; 2019 Dec; 17(1):411. PubMed ID: 31815624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.